new warnings about Chantix and an increased risk of cardiac events in patients with heart disease

August 2011

Please see updated FDA safety information regarding the risk of cardiovascular events with Chantix (varenicline).

People will worry about new warnings about Chantix and an increased risk of cardiac events in patients with heart disease.

FDA says there MIGHT be a higher risk...but this is controversial. Any cardiac risk is likely to be small...if it exists at all.

Continue to recommend Chantix (varenicline) when appropriate.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote